Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey

Document Type : Original Article

Authors

1 Center for Systematic Reviews for Health Policy and Systems Research, American University of Beirut, Beirut, Lebanon

2 Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon

3 Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA

4 Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon

5 Faculty of Medicine, American University of Beirut, Beirut, Lebanon

6 Pharmaceutical Science Master Course, University of Sorocaba, São Paulo, Brazil

7 Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada

8 Department of Internal Medicine, American University of Beirut, Beirut, Lebanon

Abstract

Background
Systematic reviews are increasingly used to inform health policy-making. The conflicts of interest (COI) of the authors of systematic reviews may bias their results and influence their conclusions. This may in turn lead to misguided public policies and systems level decisions. In order to mitigate the adverse impact of COI, scientific journals require authors to disclose their COIs. The objective of this study was to assess the frequency and different types of COI that authors of systematic reviews on health policy and systems research (HSPR) report.

 
Methods
We conducted a cross sectional survey. We searched the Health Systems Evidence (HSE) database of McMaster Health Forum for systematic reviews published in 2015. We extracted information regarding the characteristics of the systematic reviews and the associated COI disclosures. We conducted descriptive analyses.

 
Results
Eighty percent of systematic reviews included authors’ COI disclosures. Of the 160 systematic reviews that included COI disclosures, 15% had at least one author reporting at least one type of COI. The two most frequently reported types of COI were individual financial COI and individual scholarly COI (11% and 4% respectively). Institutional COIs were less commonly reported than individual COIs (3% and 15% respectively) and non-financial COIs were less commonly reported than financial COIs (6% and 14% respectively). Only one systematic review reported the COI disclosure by editors, and none reported disclosure by peer reviewers. All COI disclosures were in the form of a narrative statement in the main document and none in an online document.

 
Conclusion
A fifth of systematic reviews in HPSR do not include a COI disclosure statement, highlighting the need for journals to strengthen and/or better implement their COI disclosure policies. While only 15% of identified disclosure statements report any COI, it is not clear whether this indicates a low frequency of COI versus an underreporting of COI, or both.

Highlights

Supplementary File 1 (Download)

Supplementary File 2 (Download)

Supplementary File 3 (Download)

Keywords

Main Subjects


  1. Lavis JN. How can we support the use of systematic reviews in policymaking? PLoS Med. 2009;6(11):e1000141. doi:10.1371/journal.pmed.1000141
  2. Perrier L, Mrklas K, Lavis JN, Straus SE. Interventions encouraging the use of systematic reviews by health policymakers and managers: a systematic review. Implement Sci. 2011;6:43. doi:10.1186/1748-5908-6-43
  3. Campbell DM, Redman S, Jorm L, Cooke M, Zwi AB, Rychetnik L. Increasing the use of evidence in health policy: practice and views of policy makers and researchers. Aust New Zealand Health Policy. 2009;6:21. doi:10.1186/1743-8462-6-21
  4. Sweet M, Moynihan R. Improving Population Health: The Uses of Systematic Reviews; 2007.
  5. Fox DM. Systematic reviews and health policy: the influence of a project on perinatal care since 1988. Milbank Q. 2011;89(3):425-449. doi:10.1111/j.1468-0009.2011.00635.x
  6. Lo B, Field MJ. Conflict of Interest in Medical Research, Education, and Practice. Washington (DC): National Academies Press (US); 2009.
  7. Schunemann HJ, Osborne M, Moss J, et al. An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med. 2009;180(6):564-580. doi:10.1164/rccm.200901-0126ST
  8. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998;279(19):1566-1570.
  9. Bes-Rastrollo M, Schulze MB, Ruiz-Canela M, Martinez-Gonzalez MA. Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: a systematic review of systematic reviews. PLoS Med. 2013;10(12):e1001578. doi:10.1371/journal.pmed.1001578
  10. Forsyth SR, Odierna DH, Krauth D, Bero LA. Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Syst Rev. 2014;3:122. doi:10.1186/2046-4053-3-122
  11. Viswanathan M, Carey TS, Belinson SE, et al. AHRQ Methods for Effective Health Care. Identifying and Managing Nonfinancial Conflicts of Interest for Systematic Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013.
  12. Making sense of non-financial competing interests. PLoS Med. 2008;5(9):e199. doi:10.1371/journal.pmed.0050199
  13. Bero LA, Grundy Q. Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest. PLoS Biol. 2016;14(12):e2001221. doi:10.1371/journal.pbio.2001221
  14. Lenzer J. When is a point of view a conflict of interest? BMJ. 2016;355:i6194. doi:10.1136/bmj.i6194
  15. Panagiotou OA, Ioannidis JP. Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. J Clin Epidemiol. 2012;65(7):740-747. doi:10.1016/j.jclinepi.2012.01.008
  16. Hakoum MB, Anouti S, Al-Gibbawi M, et al. Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey. BMJ Open. 2016;6(8):e011997. doi:10.1136/bmjopen-2016-011997
  17. Hakoum MB, Jouni N, Abou-Jaoude EA, et al. Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey. J Clin Epidemiol. 2017;87:78-86. doi:10.1016/j.jclinepi.2017.04.002
  18. Health Systems Evidence. About HSE. https://www.healthsystemsevidence.org/about. Published 2016.
  19. Lavis JN, Wilson MG, Moat KA, et al. Developing and refining the methods for a 'one-stop shop' for research evidence about health systems. Health Res Policy Syst. 2015;13:10. doi:10.1186/1478-4505-13-10
  20. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381. doi:10.1016/j.jbi.2008.08.010
  21. Shawwa K, Kallas R, Koujanian S, et al. Requirements of clinical journals for authors' disclosure of financial and non-financial conflicts of interest: a cross sectional study. PLoS One. 2016;11(3):e0152301. doi:10.1371/journal.pone.0152301
  22. Khamis AM, Hakoum MB, Bou-Karroum L, et al. Requirements of health policy and services journals for authors to disclose financial and non-financial conflicts of interest: a cross-sectional study. Health Res Policy Syst. 2017;15(1):80. doi:10.1186/s12961-017-0244-2
  23. Kesselheim AS, Lee JL, Avorn J, Servi A, Shrank WH, Choudhry NK. Conflict of interest in oncology publications: a survey of disclosure policies and statements. Cancer. 2012;118(1):188-195. doi:10.1002/cncr.26237
  24. El-Jardali F, Akl EA, Karroum LB, et al. Systematic reviews addressing identified health policy priorities in Eastern Mediterranean countries: a situational analysis. Health Res Policy Syst. 2014;12:48. doi:10.1186/1478-4505-12-48
  25. Law T, Lavis J, Hamandi A, Cheung A, El-Jardali F. Climate for evidence-informed health systems: a profile of systematic review production in 41 low- and middle-income countries, 1996-2008. J Health Serv Res Policy. 2012;17(1):4-10. doi:10.1258/jhsrp.2011.010109
  26. Wilson MG, Moat KA, Lavis JN. The global stock of research evidence relevant to health systems policymaking. Health Res Policy Syst. 2013;11:32. doi:10.1186/1478-4505-11-32
  27. Oliver S, Bangpan M, Stansfield C, Stewart R. Capacity for conducting systematic reviews in low- and middle-income countries: a rapid appraisal. Health Res Policy Syst. 2015;13:23. doi:10.1186/s12961-015-0012-0
  • Receive Date: 10 January 2017
  • Revise Date: 10 October 2017
  • Accept Date: 27 December 2017
  • First Publish Date: 01 August 2018